Finally, few data have been reported on asymptomatic patients with smoldering MM (SMM) (15) thus suggesting the need to better define PD-1/PD-L1 distribution in the tumour microenvironment of patients with monoclonal gammopathies at different stages of disease. This evidence concerns the gene PDCD1 and neoplasm.